Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis

BACKGROUND: Oclacitinib (Apoquel®) inhibits the function of a variety of pro-inflammatory, pro-allergic and pruritogenic cytokines that are dependent on Janus kinase enzyme activity. Oclacitinib selectively inhibits Janus kinase 1. HYPOTHESIS/OBJECTIVES: We aimed to evaluate the safety and efficacy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Vet Dermatol
Main Authors: Cosgrove, Sallie B, Wren, Jody A, Cleaver, Dawn M, Martin, David D, Walsh, Kelly F, Harfst, Jessica A, Follis, Stacey L, King, Vickie L, Boucher, Joseph F, Stegemann, Michael R
Formato: Artigo
Idioma:Inglês
Publicado em: BlackWell Publishing Ltd 2013
Assuntos:
Scientific Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4282347/
https://ncbi.nlm.nih.gov/pubmed/23829933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/vde.12047
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados